Patents by Inventor Milton Ma

Milton Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD33 TARGETED IMMUNOTHERAPIES
    Publication number: 20260132184
    Abstract: The present disclosure provides improved CD33 targeting polypeptides and compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith.
    Type: Application
    Filed: January 12, 2026
    Publication date: May 14, 2026
    Applicants: Regeneron Pharmaceuticals, Inc., Inhibrx Biosciences, Inc.
    Inventors: Jordan Jarjour, Mark Pogson, Wai-Hang Leung, Kyle Jones, William Crago, Angelica Sanabria, Andrew Hollands, Jacob Gano, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • CD33 targeted immunotherapies
    Patent number: 12552855
    Abstract: The present disclosure provides improved CD33 targeting polypeptides and compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith.
    Type: Grant
    Filed: May 7, 2020
    Date of Patent: February 17, 2026
    Assignees: Regeneron Pharmaceuticals, Inc., Inhibrx Biosciences, Inc.
    Inventors: Jordan Jarjour, Mark Pogson, Wai-Hang Leung, Kyle Jones, William Crago, Angelica Sanabria, Andrew Hollands, Jacob Gano, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • FcRn-Binding Polypeptides and Uses Thereof
    Publication number: 20250353911
    Abstract: Provided herein are VHH-containing polypeptides that bind FcRn. Uses of the VHH-containing polypeptides are also provided.
    Type: Application
    Filed: June 9, 2023
    Publication date: November 20, 2025
    Applicant: Inhibrx Biosciences, Inc.
    Inventors: Andrew Hollands, Milton Ma, John C. Timmer, Brendan P. Eckelman, Florian Sulzmaier
  • Albumin-Binding Polypeptides and Uses Thereof
    Publication number: 20250277018
    Abstract: Provided herein are VHH-containing polypeptides that bind albumin. Uses of the VHH-containing polypeptides are also provided.
    Type: Application
    Filed: May 4, 2023
    Publication date: September 4, 2025
    Applicant: Inhibrx Biosciences, Inc.
    Inventors: Andrew Hollands, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • CD33-Binding Polypeptides and Uses Thereof
    Publication number: 20250059279
    Abstract: Provided herein are VHH-containing polypeptides that bind CD33. Uses of the VHH-containing polypeptides are also provided.
    Type: Application
    Filed: August 2, 2024
    Publication date: February 20, 2025
    Applicant: Inhibrx Biosciences, Inc.
    Inventors: Kyle S. Jones, William Crago, Angelica Sanabria, Andrew Hollands, Jacob Gano, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • CD33-binding polypeptides and uses thereof
    Patent number: 12084502
    Abstract: Provided herein are VHH-containing polypeptides that bind CD33. Uses of the VHH-containing polypeptides are also provided.
    Type: Grant
    Filed: December 16, 2022
    Date of Patent: September 10, 2024
    Assignee: Inhibrx Biosciences, Inc.
    Inventors: Kyle S. Jones, William Crago, Angelica Sanabria, Andrew Hollands, Jacob Gano, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • CD123-binding polypeptides and uses thereof
    Patent number: 11919963
    Abstract: Provided herein are VHH-containing polypeptides that bind CD123. Uses of the VHH-containing polypeptides are also provided.
    Type: Grant
    Filed: August 1, 2022
    Date of Patent: March 5, 2024
    Assignee: Inhibrx, Inc.
    Inventors: Chelsie Macedo, Kyle Jones, William Crago, Andrew Hollands, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • CD33-Binding Polypeptides and Uses Thereof
    Publication number: 20230312716
    Abstract: Provided herein are VHH-containing polypeptides that bind CD33. Uses of the VHH-containing polypeptides are also provided.
    Type: Application
    Filed: December 16, 2022
    Publication date: October 5, 2023
    Applicant: Inhibrx, Inc.
    Inventors: Kyle S. Jones, William Crago, Angelica Sanabria, Andrew Hollands, Jacob Gano, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • CD123-Binding Polypeptides and Uses Thereof
    Publication number: 20230065306
    Abstract: Provided herein are VHH-containing polypeptides that bind CD123. Uses of the VHH-containing polypeptides are also provided.
    Type: Application
    Filed: August 1, 2022
    Publication date: March 2, 2023
    Applicant: Inhibrx, Inc.
    Inventors: Chelsie Macedo, Kyle Jones, William Crago, Andrew Hollands, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • CD33-binding polypeptides and uses thereof
    Patent number: 11560428
    Abstract: Provided herein are VHH-containing polypeptides that bind CD33. Uses of the VHH-containing polypeptides are also provided.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: January 24, 2023
    Assignee: Inhibrx, Inc.
    Inventors: Kyle S. Jones, William Crago, Angelica Sanabria, Andrew Hollands, Jacob Gano, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • CD33 TARGETED IMMUNOTHERAPIES
    Publication number: 20220324942
    Abstract: The present disclosure provides improved CD33 targeting polypeptides and compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith.
    Type: Application
    Filed: May 7, 2020
    Publication date: October 13, 2022
    Applicants: 2SEVENTY BIO, INC., INHIBRX, INC.
    Inventors: JORDAN JARJOUR, MARK POGSON, WAI-HANG LEUNG, KYLE JONES, WILLIAM CRAGO, ANGELICA SANABRIA, ANDREW HOLLANDS, JACOB GANO, MILTON MA, JOHN C. TIMMER, BRENDAN P. ECKELMAN
  • CD123 TARGETED IMMUNOTHERAPIES
    Publication number: 20220315638
    Abstract: The present disclosure provides improved CD123 targeting polypeptides and compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith.
    Type: Application
    Filed: May 7, 2020
    Publication date: October 6, 2022
    Applicants: 2SEVENTY BIO, INC., INHIBRX, INC.
    Inventors: JORDAN JARJOUR, MARK POGSON, WAI-HANG LEUNG, CHELSIE MACEDO, KYLE JONES, WILLIAM CRAGO, ANDREW HOLLANDS, MILTON MA, JOHN C. TIMMER, BRENDAN P. ECKELMAN
  • CD123-binding polypeptides and uses thereof
    Patent number: 11434297
    Abstract: Provided herein are VHH-containing polypeptides that bind CD123. Uses of the VHH-containing polypeptides are also provided.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: September 6, 2022
    Assignee: Inhibrx, Inc.
    Inventors: Chelsie Macedo, Kyle Jones, William Crago, Andrew Hollands, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • CD33-Binding Polypeptides and Uses Thereof
    Publication number: 20200347133
    Abstract: Provided herein are VHH-containing polypeptides that bind CD33. Uses of the VHH-containing polypeptides are also provided.
    Type: Application
    Filed: May 1, 2020
    Publication date: November 5, 2020
    Applicant: Inhibrx, Inc.
    Inventors: Kyle S. Jones, William Crago, Angelica Sanabria, Andrew Hollands, Jacob Gano, Milton Ma, John C. Timmer, Brendan P. Eckelman
  • CD123-Binding Polypeptides and Uses Thereof
    Publication number: 20200347142
    Abstract: Provided herein are VHH-containing polypeptides that bind CD123. Uses of the VHH-containing polypeptides are also provided.
    Type: Application
    Filed: May 1, 2020
    Publication date: November 5, 2020
    Applicant: Inhibrx, Inc.
    Inventors: Chelsie Macedo, Kyle Jones, William Crago, Andrew Hollands, Milton Ma, John C. Timmer, Brendan P. Eckelman